New York State Assembly

Bill No.:  

 
•  Summary 
 
•  Actions 
 
•  Committee Votes 
 
•  Floor Votes 
 
•  Memo 
 
•  Text 
 
•  LFIN 
 
•  Chamber Video/Transcript 

---

A00689 Summary:

BILL NO	A00689
SAME AS	No Same As
SPONSOR	Rosenthal L
COSPNSR
MLTSPNSR
Add Art 2 Title 6 268, Pub Health L
Relates to the tampon safety and research act and its creation of a research program to determine the risks posed from potential toxins in feminine hygiene products.

Go to top

---

A00689 Floor Votes:

Go to top

---

A00689 Memo:

NEW YORK STATE ASSEMBLY
MEMORANDUM IN SUPPORT OF LEGISLATION
 submitted in accordance with Assembly Rule III, Sec 1(f)



 
BILL NUMBER: A689
 
SPONSOR: Rosenthal L

 
TITLE OF BILL:  An act to amend the public health law, in relation to
the creation of a research program to determine the risks posed from
potential toxins in feminine hygiene products; and providing for the
repeal of such provisions upon expiration thereof
 
 
PURPOSE:
 
This bill will establish a four-year research program through the New
York State Department of Health to determine the extent to which the
presence of dioxins, synthetic fibers, chlorine, and other components
pose health risks to individuals using feminine hygiene products.
 
 
SUMMARY OF SPECIFIC PROVISIONS:
 
Section one identifies the short title of the bill, as the Tampon Safety
and Research Act.
 
Section two amends Title 6 of article 2 of the public health law by
adding a new section 267, which provides for the definition of feminine
hygiene products and the duties of the department of health to conduct
research into the health risks of dioxins, synthetic fibers, chlorine
and other components (including contaminants and substances used as
fragrances, colorants, dyes, and preservatives) found in feminine
hygiene products.
 
Section three sets forth the effective date.
 
 
JUSTIFICATION:
 
Over the course of a lifetime, the average menstruating individual uses
as many as 16,800 tampons; whereas an individual on menopausal hormone
therapy may use as many as 24,360 tampons. Feminine hygiene products are
a necessity, thus it is essential to examine the impact they may have on
human health. We cannot prove whether diseases such as cervical cancer,
endometriosis, infertility and ovarian cancer may be linked to feminine
hygiene product use.
 
This bill establishes a four-year research program through the Depart-
ment of Health to determine whether the presence of dioxins, synthetic
fibers, chlorine, and other components pose any health risks to feminine
hygiene product user.
 
 
LEGISLATIVE HISTORY:
 
2017-18: A.572 - Referred to Health
 
 
FISCAL IMPLICATIONS:
 
Undetermined.
 
 
EFFECTIVE DATE:
This act shall take effect on the nineteenth day after it shall have
become law and shall expire and be deemed repealed five years after such
date.

Go to top